RYR2 Channel Inhibition Is the Principal Mechanism 0f Flecainide Action in CPVT
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RYR2 Channel Inhibition Is the Principal Mechanism 0f Flecainide Action in CPVT
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-12-10
DOI
10.1161/circresaha.120.316819
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sarcoplasmic Reticulum Ca 2+ Release Uses a Cascading Network of Intra-SR and Channel Countercurrents
- (2018) Vilmos Zsolnay et al. BIOPHYSICAL JOURNAL
- Effect of flecainide derivatives on sarcoplasmic reticulum calcium release suggests a lack of direct action on the cardiac ryanodine receptor
- (2016) Mark L Bannister et al. BRITISH JOURNAL OF PHARMACOLOGY
- Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes
- (2015) Eleonora Savio-Galimberti et al. PLoS One
- Control of Sarcoplasmic Reticulum Ca2+ Release by Stochastic RyR Gating within a 3D Model of the Cardiac Dyad and Importance of Induction Decay for CICR Termination
- (2013) M.B. Cannell et al. BIOPHYSICAL JOURNAL
- Flecainide reduces Ca2+ spark and wave frequency via inhibition of the sarcolemmal sodium current
- (2013) Markus B. Sikkel et al. CARDIOVASCULAR RESEARCH
- Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia
- (2013) Hiroshi Watanabe et al. HEART RHYTHM
- HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
- (2013) Silvia G. Priori et al. HEART RHYTHM
- ß-Adrenergic Stimulation Increases RyR2 Activity via Intracellular Ca2+ and Mg2+ Regulation
- (2013) Jiao Li et al. PLoS One
- Mutations in Calmodulin Cause Ventricular Tachycardia and Sudden Cardiac Death
- (2012) Mette Nyegaard et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Novel molecular targets for atrial fibrillation therapy
- (2012) Dobromir Dobrev et al. NATURE REVIEWS DRUG DISCOVERY
- Mechanism of Antiarrhythmic Effects of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
- (2011) Hiroshi Watanabe et al. CIRCULATION RESEARCH
- Short Communication: Flecainide Exerts an Antiarrhythmic Effect in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia by Increasing the Threshold for Triggered Activity
- (2011) Nian Liu et al. CIRCULATION RESEARCH
- Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin
- (2011) Eleonora Savio Galimberti et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
- (2011) Christian van der Werf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
- (2009) Hiroshi Watanabe et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search